IDEXX LABORATORIES INC /DE
(IDXX)CIK 874716 · SEC filings only
harness minimum not met
Not enough resolved promises to grade
0 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.
buyback history
Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.
See Pro →Open promises (1)
Outlook assumes ~$1.5 billion of share repurchases in 2025
grade
Sector median (Life Sciences): B across 7 graded companies
Resolved promises
Full say-do history
Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.
See Pro →Guidance by basis
6 of 12 guidance figures that were graded or dropped for basis could not be graded on the same basis (50%). Guidance marked “not judged” is in neither number.
| Guidance type | Said | Graded | Dropped | Other |
|---|---|---|---|---|
| Revenue · basis not stated | 28 | 6 | 0 | 22 |
| EPS · basis not statedcannot be graded | 23 | 0 | 6 | 17 |
Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.
Guidance shown, not graded (23)
We show what was said — with its source filing — but never score it. The line under each statement says why.
- eps guidance fy · Aug 4, 2026Increases 2026 EPS outlook to $14.69 - $14.94Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 2, 2026Projects 2026 EPS of $14.29 - $14.80Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Nov 3, 2025Raises 2025 EPS outlook to $12.81 - $13.01Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Aug 4, 2025Updates 2025 EPS outlook to $12.40 - $12.76Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · May 1, 2025Updates 2025 EPS outlook to $11.93 - $12.43Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 3, 2025Estimates 2025 EPS of $11.74 - $12.24Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 31, 2024Narrows 2024 EPS outlook to $10.37 - $10.53Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Aug 6, 2024Adjusts 2024 EPS outlook to $10.31 - $10.59Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · May 1, 2024Updates 2024 EPS outlook to $10.82 - $11.20Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 5, 2024Estimates 2024 EPS of $10.84 - $11.33Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Nov 1, 2023Updates 2023 EPS outlook to $9.74 - $9.90Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Aug 1, 2023Increases 2023 EPS outlook to $9.64 - $9.90Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · May 2, 2023Updates 2023 EPS outlook to $9.33 - $9.75Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 6, 2023Estimates 2023 EPS of $9.27 - $9.75Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Nov 1, 2022The Company's EPS outlook of $7.74 - $7.98Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Aug 2, 2022The Company's EPS outlook of $7.77 - $8.05Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · May 4, 2022The Company's EPS outlook of $8.11 - $8.35Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 2, 2022Estimates 2022 EPS of $9.27 - $9.59Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Nov 2, 2021EPS $8.30 - $8.38Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jul 30, 2021Raises 2021 EPS outlook to $8.20 - $8.36Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · May 4, 2021Raises 2021 EPS outlook to $7.88 - $8.18Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 2, 2021Estimates 2021 EPS of $7.39 - $7.71Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 1, 2019We are increasing our 2019 EPS outlook to $4.66 - $4.78 per shareUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
Open promises (1) · 21 superseded
Narrows 2026 revenue guidance to $4,700 million - $4,745 million
Increases 2023 revenue guidance to $3,615 million - $3,700 million
Provides initial outlook for 2023 revenue of $3,590 million - $3,690 million
Provides initial outlook for 2025 revenue of $4,055 million - $4,170 million
Provides initial outlook for 2021 revenue of $3,065 million - $3,120 million
Provides initial outlook for 2024 revenue of $3,930 million - $4,040 million
The Company is updating its full year revenue growth outlook to 3% - 5.5% as reported and 5.5% - 8% organically
Provides initial outlook for 2026 revenue guidance range of $4,632 million - $4,720 million
reflecting a range of 9.1% - 10.3%
Adjusts 2025 revenue guidance to $4,095 million - $4,210 million
Increases 2021 revenue guidance to $3,170 million - $3,205 million
Updates 2024 revenue growth guidance to 5.5% - 6.2% as reported
Updates 2023 revenue guidance to $3,660 million - $3,715 million
Provides initial outlook for 2022 revenue of $3,500 million - $3,565 million
Updates 2024 revenue guidance to $3,885 million - $3,945 million
Updates guidance for 2025 reported revenue growth to 7.7% - 9.7%
Re-calibrated 2022 revenue outlook reflects 5.5% - 8% reported growth
Updates outlook for 2025 reported revenue growth of 9.6% - 10.3%
Increases 2021 revenue guidance to $3,105 million - $3,160 million
Updates 2024 revenue guidance to $3,895 million - $3,965 million
Updates guidance for 2025 reported revenue growth to 5% - 8%
Increases 2025 revenue guidance to $4,205 million - $4,280 million
Credibility timeline
Timeline as a list
- Feb 14, 2020IN LINEThe Company is reaffirming its 2019 revenue outlook of $2,385 million - $2,425 million
- Feb 16, 2022ABOVERevenue $3,185 - $3,200
- Feb 16, 2023ABOVEThe Company is updating its full-year revenue growth outlook to 3.5% - 4.5% as reported and 6.5% - 7.5% organically.
- Feb 22, 2024ABOVEAdjusts 2023 revenue guidance to $3,635 million - $3,650 million
- Feb 21, 2025ABOVEAdjusts 2024 revenue guidance to $3,865 million - $3,890 million
- Feb 20, 2026ABOVEIncreases 2025 revenue guidance to $4,270 million - $4,300 million